STRATA CRITICAL MEDICAL, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- STRATA CRITICAL MEDICAL, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $3.00K, a 78.57% decline year-over-year.
- STRATA CRITICAL MEDICAL, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $52.00K, a 13.33% decline year-over-year.
- STRATA CRITICAL MEDICAL, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-12-31 was $54.00K, a 22.73% increase year-over-year.
- STRATA CRITICAL MEDICAL, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $65.00K, a 490.91% increase year-over-year.
- STRATA CRITICAL MEDICAL, INC. stock issued during period, value, stock options exercised for fiscal 2025 was $193.00K, a 14.88% increase from fiscal 2024.
- STRATA CRITICAL MEDICAL, INC. stock issued during period, value, stock options exercised for fiscal 2024 was $168.00K, a 140.00% increase from fiscal 2023.
- STRATA CRITICAL MEDICAL, INC. stock issued during period, value, stock options exercised for fiscal 2023 was $70.00K, a 19.54% decline from fiscal 2022.
- STRATA CRITICAL MEDICAL, INC. stock issued during period, value, stock options exercised for fiscal 2022 was $87.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $3.00K 10-Q · filed 2026-08-04 | $174.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $52.00K 10-Q · filed 2026-05-06 | $185.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $54.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $193.00K 10-K · filed 2026-03-03 |
| 2025-09-30 | $65.00K 10-Q · filed 2025-11-10 | $183.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $14.00K 10-Q · filed 2026-08-04 | $129.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $60.00K 10-Q · filed 2026-05-06 | $137.00K derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $44.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $168.00K 10-K · filed 2026-03-03 |
| 2024-09-30 | $11.00K 10-Q · filed 2025-11-10 | $131.00K derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $22.00K 10-Q · filed 2025-08-05 | $129.00K derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $91.00K 10-Q · filed 2025-05-12 | $107.00K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $70.00K 10-K · filed 2025-03-13 |
| 2023-09-30 | $9.00K 10-Q · filed 2024-11-12 | $150.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $143.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $54.00K 10-Q · filed 2024-05-07 | $201.00K derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $87.00K 10-K · filed 2023-03-16 | $87.00K 10-K · filed 2024-03-12 |
| 2022-09-30 | $2.00K 10-Q · filed 2023-11-08 | $242.00K derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $58.00K 10-Q · filed 2023-08-09 | $360.00K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $21.00K 10-Q · filed 2023-05-11 | $307.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $161.00K 10-K · filed 2023-03-16 | $303.00K derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-09-30 | $120.00K 10-Q · filed 2022-11-10 | $144.00K 10-K · filed 2023-03-16 |
| 2021-06-30 | $5.00K 10-Q · filed 2022-08-09 | $34.00K derived: sum of 4 quarters · filed 2023-01-10 |
| 2021-03-31 | $17.00K 10-Q · filed 2022-05-10 | |
| 2020-12-31 | $2.00K 8-K · filed 2023-01-10 | |
| 2020-09-30 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-20 | $15.00K 10-K · filed 2021-12-20 |
| 2019-09-30 | $116.00K 10-K · filed 2021-12-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |